Stelara (Ustekinumab) for Psoriasis

Overview
Stelara is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children 6 years old and older who have moderate to severe plaque psoriasis and adults with active psoriatic arthritis. Stelara is also known by its drug name, ustekinumab.

Stelara is a biologic. Stelara is a genetically engineered antibody, a protein used by the immune system to identify and neutralize substances. Stelara is believed to work by targeting specific proteins in the immune system and reducing inflammation.

How do I take it?
Stelara is injected by a doctor or nurse once every four weeks for the first two doses. After the first two doses, Stelara is injected once every 12 weeks.

Side effects
Common side effects listed on the FDA-approved label for Stelara include upper respiratory infections, headache, and fatigue.

Rare but serious side effects listed for Stelara include tuberculosis, hypersensitivity reactions, noninfectious pneumonia, increased risk for certain types of cancer, and a dangerous illness called reversible posterior leukoencephalopathy syndrome.

For more information about this treatment, visit:

Stelara — Janssen
https://www.stelarainfo.com/plaque-psoriasis